List view / Grid view

RedHill Biopharma

Filter the results

 

news

First patients dosed in Bekinda IBS-D trial

22 June 2016 | By Victoria White, Digital Content Producer

The first patients have been dosed in a Phase II clinical study with RedHill Biopharma’s Bekinda 12 mg for diarrhoea-predominant irritable bowel syndrome...